Single-Channel Analysis of the Molecular Pharmacology of the Long QT Syndrome Variant 3  by Robey, Seth H. et al.
584a Wednesday, February 11, 2015the extracellular region. Rewiring effect of inter-residue interactions in 493R
mutant pocket allosterically propagates across the channel resulting in a
more stabilized global conformational ensemble of the channel. These findings
predict a novel mechanism of ENaC’s constitutive activity, in which changes
in local dynamics can affect the relative population of the channel’s active
states and its open probability.
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As a member of the ATP-binding cassette (ABC) protein superfamily, CFTR, a
phosphorylation-activated but ATP-gated chloride channel, is comprised of
two transmembrane domains (TMDs) that form a gated anion conducting
pore and two nucleotide binding domains (NBDs) whose dimerization/dissoci-
ation is allosterically coupled to opening/closing of the gate. Recent cysteine
scanning of CFTR’s TMDs not only identified pore-lining residues, but also
suggested molecular motions of the TMDs involved in opening/closing
of the ‘‘gate’’. Since many of the pore-lining residues exhibit clear state-
dependent exposure to the aqueous pore, it is predicted that mutations at these
positions might affect gating by altering the free energy level of a particular
state. T338 was chosen because this pore-lining residue is mostly concealed
from the pore in the closed state. We converted T338 to various amino acids
and found that the physical properties of the side-chain at this position indeed
affect CFTR gating as well as anion conductance. For hydrophilic residues like
threonine itself (0.575 0.06, n ¼ 4), serine (0.455 0.02, n ¼ 12) and aspar-
agine (0.88 5 0.02, n ¼ 6), the larger the side-chain, the higher the Po. In
contrast, for hydrophobic ones such as alanine (0.605 0.02, n ¼ 6), isoleucine
(0.195 0.03, n¼ 6) and valine (0.445 0.05, n ¼ 7), the larger the side-chain,
the lower the Po. Single-channel kinetic analysis revealed that mutations
mainly affect the open time. To exclude possible effects of the mutation on
ATP hydrolysis, we introduced some mutations into the E1371S background,
whose ATP hydrolysis is abolished. Interestingly, mutations that shorten the
open time under the wild-type background also decrease significantly the Po
in E1371S. The implications of our data on the gating and permeation mecha-
nisms for CFTR will be discussed.
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Introduction: The cardiac Naþ/Ca2þ exchanger 1 (NCX1) modulates
excitation-contraction coupling and contributes to Ca2þ removal in cardiomyo-
cytes. Altered expression and activity of NCX1 is linked to dysfunctional Ca2þ
handling in chronic heart disease. Consequently, modulation of NCX1 activity
is proposed as a therapeutic target. The cytosolic loop of NCX1, ~550 amino
acids, comprises several important docking and regulation sites. In particular,
phospholemman (PLM) has been shown to interact and inhibit NCX1 activity
when phosphorylated at serine 68 (pSer68-PLM). Importantly, pSer68-PLM
has been shown as a substrate for protein phosphatase 1 (PP1) in the context
of PLM regulation of the sodium-potassium pump. PP1 regulation of NCX1
is unknown.
Hypothesis: PP1 binds to NCX1 and regulates its activity by dephosphorylat-
ing pSer68-PLM.
Methods and Results: Using co-immunoprecipitation in rat heart lysates we
have shown that NCX1 exists in a macromolecular complex with PP1 and
PLM. This facilitates specific control of NCX function. Bioinformatic analysis
revealed three putative PP1 binding sites on NCX1. Co-localization studies,
co-immunoprecipitations, pull down, mutation- and peptide overlay assays
indicated that PP1 bound directly to the consensus sequence R/KVxF in cal-
cium binding domain 1 (CBD1) of NCX1. The reciprocal NCX1 binding site
in PP1 was identified within residues 235-260, a region which harbours
important anchoring sites. A peptide docking model was generated showing
how the R/KVxF peptide may bind in the hydrophobic pocket of PP1. Surface
plasmon resonance analysis indicated that the NCX1-PP1 binding is strong
and stable. This binding does not inhibit PP1 activity. Co-expression of
NCX1 with PLM and PP1 in HEK293 down regulates pSer68-PLM, indi-cating that PP1-R/KVxF- binding is a prerequisite for dephosphorylation of
pSer68-PLM.
Conclusion: R/KVxF motif in NCX1-CBD1 anchors PP1, does not change the
activity of the enzyme and facilitates dephosphorylation of pSer68-PLM.
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The pore-domain of TRPA1 mediates the inhibitory effect of the antagonist
6-Methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole
The ion channel TRPA1 gives to the organisms the ability to detect noxious
chemicals to sensory neurons and as a result of this, mediates chemical nocicep-
tion in vivo. Mouse TRPA1 is activated by electrophilic compounds such as
mustard-oil (MO) and several physical stimuli such as cold temperature.
Both stimuli are mechanistic linked to the N terminus of the channel. Due to
its sensory function, the inhibition of TRPA1 activity might provide an effec-
tive treatment against chronic and inflammatory pain, for that reason, TRPA1
has become an important target for the development of new and better analgesic
drugs. 6-Methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole (Compound 31)
has been identified by a chemical screen and lead optimization as an inhibitor
of chemical activation of TRPA1. However, the structures or domains of
TRPA1 that mediate the inhibitory effect of Compound 31 are unknown.
Here, we screened 12,000 random mutant clones of mouse TRPA1 for their
sensitivity to mustard-oil and the ability of Compound 31 to inhibit chemical
activation by MO. We identified five mutations located within the pore domain
that cause loss of inhibition by Compound 31, one of them in the residue T877
placed in the TM5, important in the binding of menthol, a dose-dependent
agonist/blocker. This result demonstrates that the pore-domain is a regulator
of chemical activation and suggests that Compound 31 might be acting directly
on the pore-domain.
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Response to mechanical stimuli, which includes proper development of biolog-
ical tissues and organs, is essential to the cell. Mechanosensitive ion channels
are the basic elements among mechanosensing molecules and complexes.
Although the traditional patch clamp technique using glass micropipettes is
still widely used for electrophysiology, it is difficult to control the mechanical
stimulus to ion channels in this system. Here we developed a novel patch clamp
system with a planar stretchable electrode to record mechanosensitive re-
sponses of ion channels. Planar electrodes of 100 mm thickness were fabricated
using silicone resin. Next, we prepared HEK293 cells transfected with the
stretch-activated KCa (SAKCA) channel, which is mechanosensitive, for
planar patch clamp recordings. Using our planar patch clamp system, a giga-
ohm seal was achieved with a maximum seal resistance of 10 GU. The success
rate of gigaohm seal formation was 37%. Then we recorded single channel
currents with a slope conductance of 285.4 pS, which is parallel to the known
SAKCA current. Using scanning electron microscope, we confirmed elonga-
tion of the aperture by 37.7% when 50% stretch was applied to the planar
electrode. It is expected that a controllable and sufficient stretch stimulus can
be applied to the cellular membrane using our newly developed planar patch
clamp system.
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The Long QT Syndrome (LQTS) is characterized by a prolongation of the QT
interval on an ECG and occurrences of ventricular fibrillation, polymorphic
ventricular tachycardia, and sudden cardiac death. In patients with LQTS
variant 3 (LQT3), mutations in the cardiac sodium channel alpha subunit,
Nav1.5, disrupt channel inactivation by multiple mechanisms and can cause
a sustained depolarizing current (INaL) sufficient to prolong the ventricular
action potential. LQT3 mutant sodium channels are therefore a reliable exper-
imental model for the study of the function and pharmacology of dysfunctional
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linked by disease-altered INaL, including ischemic heart disease and heart fail-
ure. While preferential pharmacological block of INaL by several Na
þ-channel
blocking drugs has proven to be an important and useful clinical approach to
manage LQT-3 arrhythmias, we still lack a fundamental understanding of the
pharmacological determinants of this selectivity. We have previously identified
a novel lethal LQT3 variant, F1473C, which displays slowed inactivation,
altered channel availability, and a significant INaL. Here we report for the first
time single channel recordings from F1473C channels and find that late reopen-
ing events during prolonged depolarizations underlie pathological INaL for this
mutation. To further unravel the mechanism of action of of Ranolazine, a drug
known to preferentially block INaL, we studied its effects on single F1473C
channels. Ranolazine reduced the number of late reopening events in a manner
consistent with block of whole cell currents. These experiments represent the
first exploration of the block of INaL caused by late reopening, and present a
framework for further studies of the mechanisms of drug block in these
channels.
2954-Pos Board B384
Automated Patch-Clamp Pharmacology Assays using Human Induced
Pluripotent Stem Cell-Derived Cardiomyocytes
Olaf Scheel1, Stefanie Frech1, Bogdan P. Amuzescu2,1, Jo¨rg Eisfeld1,
Kun-Han Lin1, Thomas Knott1.
1Cytocentrics Bioscience GmbH, Rostock, Germany, 2Biophysics &
Physiology, Faculty of Biology, University of Bucharest, Bucharest,
Romania.
Recent progress in the field of embryonic and induced pluripotent stem cell
(iPSC)-derived cardiomyocytes led to flourishing of a variety of pharma-
cology and drug safety screening assays, relying on diverse principles,
such as optical measurements using wide dynamic range Ca2þ-sensitive or
transmembrane voltage-sensitive dyes, or multi-electrode arrays allowing
field potential measurements, action potential (AP) conduction velocity and
2D local activation mapping, and impedance changes in cultured monolayers.
In view of new recommendations of the cardiac in vitro pro-arrhythmia
(CiPA) consortium of multiple ion channel pharmacology assessment
(MICE), combined with AP and electrophysiology model-based testing of
arrhythmia-prone conditions, we developed a complex automated patch-
clamp assay, combining current-clamp and voltage-clamp protocols, appli-
cable to commercial high-purity human iPSC-derived cardiomyocyte prepa-
rations, e.g. iCell Cardiomyocytes or Cor.4U cardiomyocytes with the
CytoPatch 2 equipment. To study stimulus-triggered APs we suppressed
spontaneous firing via continuous injection of a faint hyperpolarizing current
(10 or 20 pA), and for removal of fast oscillations during rapid AP up-
stroke we applied a 60 Hz Gaussian filter implemented in Clampfit10. APs
were analyzed for automated measurement of resting and peak potential,
maximum phase 0 slope (dV/dtmax), and various AP durations: APD10,
APD50, APD90. Nifedipine elicited pacing frequency-dependent reductions
in APD50 (16.1% and 12.0% of control values at 1 and 10 mM, respectively),
cisapride 0.1 mM prolonged APD90 to 176.2%, and TTX 10 mM decreased
dV/dtmax to 33.3% and APD90 to 80.4% of control values. Voltage-clamp
measurements evidenced a progressive increase from 10 to 15 days in vitro
(d.i.v.) for densities (pA/pF, mean5SD) of peak Naþ current (119.6567.3 to
406.75799.2), L-type Ca2þ current (2.7452.84 to 3.4354.05), plateau cur-
rent within a 2-s depolarizing pulse at þ40 mV (1.2851.42 to 3.1654.68),
while transient outward current was more steady (0.7751.14, 10 d.i.v. and
0.6150.75,14 d.i.v.).
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Glutamate NMDA receptors are increasingly employed in drug discovery for
numerous clinical indications. Multiple receptor isoforms with distinct brain
distributions and properties arise by selective splicing of the NR1 transcripts
and differential expression of NR2 (A-D) subunit subtypes of NMDA recep-
tors. NR1/NR2A and NR1/NR2B represent the most abundant subtypes.
Recent advances in electrophysiology-based HTS assays however, demand
renewed characterization of these receptors on automated patch clamp plat-
forms. In this study we used IonWorks Barracuda, an HTS platform that
can operate in 384-well format, population patch clamp (PPC) mode. Side-
by-side comparisons of pharmacological properties of NR1/NR2A and
NR1/NR2B glutamate receptor responses to L-glutamate and NMDA, phar-
macological profiling and comparison of eight competitive and uncompetitiveinhibitors and comparison of kinetic of responses were obtained in ‘‘single
hole’’ (SH) and PPC modes. Experiment protocols were developed to
routinely produce signals ~2 nA and ~1 nA for NR1/NR2A and NR1/
NR2B, respectively, in PPC mode. Under our experimental procedures both
NR1/N2A and NR1/NR2B showed good uniformity with Z’ factor > 0.6.
We found that EC50 concentrations for L-glutamate were 3.8 mM and
2.0 mM for NR1/NR2A and NR1/NR2B, respectively. NMDA appeared to
be a less potent partial agonist at NR1/NR2B (>75% and EC50¼18-
20 mM), whereas NMDA appeared to be a full agonist at NR1/NR2A with
EC50 ¼ 100 mM. These EC50 values were consistent with literature data
obtained with conventional manual patch clamp methods. Additionally, we
confirmed selectivity of the uncompetitive inhibitor, ifenprodil, towards
NR1/NR2B receptors with IC50Ifen¼ 19.3 mM, whereas NR1/NR2A recep-
tors were unaffected. Potential variability in IC50 values of uncompetitive
inhibitors due to open-pore dependence will be discussed. Our data demon-
strate the potential of a robust HTS patch clamp assay for profiling new
chemical entities against NMDA receptor subtypes.
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Cystic Fibrosis (CF) is a genetically-inherited disease characterized by the
loss of function of the Cystic Fibrosis Transmembrane Conductance Regu-
lator (CFTR), a chloride ion channel located in the epithelial lining of
the lungs and pancreas. CFTR function is reduced or eliminated as the
result of a variety of genetic mutations, leading to harmful fluid buildup,
decreased organ function, and eventually death. Our goal is to identify and
characterize the molecular interactions of several disease-relevant mutations
of CFTR with a variety of small molecule modulators of the protein. To
this end, we use a highly-sensitive label-free detection method based on
backscattering interferometry (BSI). By displaying CFTR in a native mem-
brane environment, we have observed and characterized the interactions
of several small molecule modulators, obtaining both binding affinities and
structural information about CFTR. This information has allowed us to
conclusively determine the previously unknown binding site for one of these
modulators.
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Dantrolene is a muscle relaxant that has been used clinically as the treatment
for malignant hyperthermia. Dantrolene acts on skeletal and cardiac muscle
by inhibiting Ca2þ release from the SR. However, single channel studies fail
to see any effect of dantrolene on RyRs. Calmodulin (CaM) regulates RyR2
directly by binding to RyR2 and dantrolene influences CaM binding to
RyR2. CaM can dissociate from RyR2 within ~1 min so when RyR2 are iso-
lated form cells and examined in artificial lipid bilayers, CaM is not usually pre-
sent. Thus, we hypothesized that CaM is the missing protein required for
dantrolene inhibition of RyR2.
Single channel recordings were obtained from RyR2 isolated from sheep
heart and incorporated into artificial lipid bilayers. Control RyR2 activity
was measured for periods of 1 min, and then during 1 min exposure to
dantrolene and then again after washout. This was repeated in the absence
and presence of exogenous 100 nM CaM. In diastolic cytoplasmic [Ca2þ]
(100 nM), dantrolene (50 mM) reduced the mean open probability of RyR2
to 45 5 6 % in the presence of CaM (n ¼ 7, p < 0.05, student paired
t-test) but had no significant effect when CaM was absent (95 5 9 %,
n¼20, p ¼ 0.24). Dantrolene exhibited a hyperbolic dose-response in the
presence of CaM with an IC50 of 0.165 0.03 mM and with a saturating rela-
tive Po (Emax) of 52 5 4 %. Emax increased to one as cytoplasmic Ca
2þ was
increased to levels above 1 mM.
In saponin permeablized mouse cardiomyocytes supplemented with 100 nM
CaM, dantrolene reduced the frequency and amplitude of Ca2þ waves
with an IC50 of 0.3 mM. However, when cells were depleted of CaM,
dantrolene had no effect. Thus CaM is essential for inhibitory action of
dantrolene.
